Username:
Password:
   
Create an Account
 
Account
Curriculum
Transcript
Preferences
 
Welcome & Mission Statement
FAQs
User Technical Support
Accreditation Legend
System Requirements
 
AAMC CME
ABMS
ACCME
AHRQ
AMA
CDC
MBC
 
This activity already occurred and is no longer available.
The Fourth National Clinical Conference on Cannabis Therapeutics
Purpose and Educational Objectives:
Upon completion of the educational activity, participants should be able to:

1. Develop a working knowledge on how the new research findings on the endogenous cannabinoids and cannabinoid receptor sites have helped in the understanding of the role of cannabis/cannabinoids in symptom management;
2. Be able to describe at least 5 therapeutic applications for cannabis;
3. Identify the potential health risks related to the use of whole cannabis;
4. Identify the potential health benefits of whole cannabis;
5. Discuss the current research on cannabis/cannabinoid product developments that offer alternatives to smoking cannabis;
6. Describe how federal, state and local laws affect clinical practice as they relate to the therapeutic use of cannabis.

Fee:
Before accessing the activity, you will be prompted to enter payment information. An enrollment fee of $100 will be charged to access the material.



blue line 
Learning Objectives:
Upon completion of the educational activity, participants should be able to:
  • Develop a working knowledge on how the new research findings on the endogenous cannabinoids and cannabinoid receptor sites have helped in the understanding of the role of cannabis/cannabinoids in symptom management;
  • Be able to describe at least 5 therapeutic applications for cannabis;
  • Identify the potential health risks related to the use of whole cannabis;
  • Identify the potential health benefits or whole cannabis;
  • Discuss the current research on cannabis/cannabinoid product developments that offer alternatives to smoking cannabis;
  • Describe how federal, state and local laws affect clinical practice as they relate to the therapeutic use of cannabis.
blue line 
Method of Participation/Instructions for Obtaining Credit:
CME credit is obtained upon completion of the program content and submission of the activity evaluation.
  1. Click the Continue link at the bottom of this page.
  2. Before accessing the activity, you will be prompted to enter payment information. An enrollment fee of $100 will be charged to access the material.
  3. Click the Activity link to begin your course.
  4. Upon completion of the modules, click the Evaluation link to complete the evaluation.
  5. Your certificate of credit will be available immediately to print for your records.
  6. You may view or print your certificate at any time in the future
blue line
Estimated Time
The estimated time to complete this activity is 5 hours, which is equivalent to 5 credits.

blue line
Media Format(s):
Online video presentations
Technical Recommendations: Free Adobe Flash Player.

blue line
Released: September, 2010; Expired: September, 2013

blue line
Accreditation:
The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

UCSF designates this enduring material for a maximum of 5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

blue line
Faculty:

Donald Abrams, MD
Professor of Hematology-Oncology, University of California, San Francisco
San Francisco, CA

David Bearman, MD
Practicing Physician,
Santa Barbara, CA

Marty Blum
Mayor,
Santa Barbara, CA

Bill Britt
Post Polio Patient,
California Nurses Association Representative,
Long Beach, CA

Nancy Cavanaugh, RN, & Son
Family of Deceased Patient,
Hills, CA.

Al Byrne
Co-founder, Patients Out of Time,
Howardsville, VA.

Joan Dangerfield
Widow of Cannabis Patient,
Santa Barbara, CA.

Marta Duran Delmas, MD
Researcher, Fundacio Institut Catala de Farmocoligia,
Barcelona, Spain.

Rick Doblin, PhD
Founder, Multidisciplinary Association of Psychedelic Studies,
Sarasota, FL

Barbara Douglass,
IND Patient, MS,
Lakeside, IA

Melanie Dreher, RN, PhD, FAAN
Dean College of Nursing, University of Iowa,
Iowa City, IA

Jon Gettman, PhD
Senior Fellow, George Mason University,
Fairfax, VA

Ed Glick, RN
Practicing Nurse,
Monmouth, OR

Erin Hildebrandt, Patient
Executive Director, Parents Ending Prohibition,
Lafayette, OR

Steve Hosea, MD
Practicing Physician, Cottage Hospital,
Santa Barbara, CA

Natalya Kogan, PhD
Researcher, Hebrew University
Jerusalem, Israel

Christopher Largen
Patient
Denton, TX

Arnold Leff, MD, MS
Practicing Physician, PACE Clinic,
San Jose, CA

Frank Lucido, MD
Practicing Physician,
Berkeley, CA

Mary Lynn Mathre, RN, MSN, CARN
Co-founder, Patients Out of Time,
Howardsville, VA

George McMahon
IND Patient, Nail Patella Syndrome,
Livermore, IA

Harriet Miller
Former Mayor of Santa Barbara,
Former Executive Director of AARP,
Santa Barbara, CA

Mark Miller
Drug Educator,
Oregon City, OR

Robert Melamede, PhD
Associate Professor, University of Colorado,
Colorado Springs, CO

Elvy Musikka,
IND Patient,
Glaucoma, Eugene, OR

Alice O’Leary LPN
Co-founder of ACT,
Sarasota, FL

Russell Peterson,
Patient
San Luis Obispo, CA

Irv Rosenfeld
IND Patient,
Multiple Congenital Cartilaginous Exostoses,
Lauderhill, FL

Debbie Rosenfeld
Patient’s Wife,
Lauderhill, FL

Rita Solinas
Patient,
Santa Barbara, CA

M.J. van de Velde, PhD, MBA
Head, Office of Medical Cannabis,
The Netherlands

Mark Wallace, MD
Associate Clinical Professor of Anesthesiology, University of California, San Diego
San Diego, CA

Mark Ware, MSc, MRCP
Assistant Professor of Family Medicine and Anesthesia, McGill University,
Montreal, Canada

Montel Williams
Patient, MS,
New York, NY
blue line
Disclosure:
The speakers listed above, moderators and planning committee members have disclosed NO financial interest/arrangement or affiliation with any commercial companies who have provided products or services relating to their presentation(s) or commercial support for this continuing medical education activity.

This UCSF CME educational activity was planned and developed to: uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and, include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.

This activity has been reviewed and approved by members of the UCSF CME Governing Board in accordance with UCSF CME accreditation policies. Office of CME staff, planners, reviewers, and all others in control of content have disclosed they have no relevant financial relationships.

blue line
Supplemental Material:
Cultural and Linguistic Competency Resources
blue line
UC Online Privacy Policy

https://www.cme.ucsf.edu/cme/policy.aspx 

blue line

Software Requirements:

PC
Microsoft Windows 2000 SE or above.
Internet Explorer (v5.5 or greater), or Firefox
Flash Player Plug-in (9.0 or later) Check your version here.
Sound Card & Speakers
800 x 600 Minimum Monitor Resolution (1024 x 768 Recommended)
Adobe Acrobat Reader*

MAC
MAC OS 10.2.8
Safari or Firefox
Flash Player Plug-in (9.0 or later) Check your version here.
Sound Card & Speakers
800 x 600 Minimum Monitor Resolution (1024 x 768 Recommended)
Adobe Acrobat Reader*
Internet Explorer is not supported on the Macintosh.
* Required to view printable (PDF) version of the lesson.

Type:     Internet Activity (Enduring Material)
60 Registered Users
Credits
5 Credits> Accreditation Council for Continuing Medical Education> AMA PRA Category 1 Credit™


Copyright© | Premier Inc. All rights reserved.
Terms of Use | Privacy Policy
Registered trademarks of Premier Inc.